Rivaroxaban trials for Atrial fibrillation

All Rivaroxaban trials · All Atrial fibrillation trials

Phase breakdown

Recruiting trials studying Rivaroxaban for Atrial fibrillation

• COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
  NCT04642430 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
  NCT06953726 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 5 locations
• Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation
  NCT06216769 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 89 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Rivaroxaban for Atrial fibrillation?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.